Corrigendum

Wang XJ, Wong SH, Givergis R, Chynn EW. Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK. Clin Ophthalmol. 2011;5:1451-1457.On page 1456 the Acknowledgment section details were incomplet...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chynn EW, Givergis R, Wong SH, Wang XJ
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://doaj.org/article/9e8cc5f836c543cd99d613e62ca1fa01
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9e8cc5f836c543cd99d613e62ca1fa01
record_format dspace
spelling oai:doaj.org-article:9e8cc5f836c543cd99d613e62ca1fa012021-12-02T02:35:59ZCorrigendum1177-54671177-5483https://doaj.org/article/9e8cc5f836c543cd99d613e62ca1fa012011-10-01T00:00:00Zhttp://www.dovepress.com/-corrigendum--a8566https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Wang XJ, Wong SH, Givergis R, Chynn EW. Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK. Clin Ophthalmol. 2011;5:1451-1457.On page 1456 the Acknowledgment section details were incomplete. The corrected Acknowledgment section is: ISTA Pharmaceuticals Inc provided ketorolac tromethamine ophthalmic solution 0.5% and bromfenac sodium ophthalmic solution 0.09% free of charge for this study and monetary compensation to the subjects to encourage participation. Dalton and Associates provided medical editing expertise.Original ArticleChynn EWGivergis RWong SHWang XJDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2011, Iss default, Pp 1557-1558 (2011)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Chynn EW
Givergis R
Wong SH
Wang XJ
Corrigendum
description Wang XJ, Wong SH, Givergis R, Chynn EW. Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK. Clin Ophthalmol. 2011;5:1451-1457.On page 1456 the Acknowledgment section details were incomplete. The corrected Acknowledgment section is: ISTA Pharmaceuticals Inc provided ketorolac tromethamine ophthalmic solution 0.5% and bromfenac sodium ophthalmic solution 0.09% free of charge for this study and monetary compensation to the subjects to encourage participation. Dalton and Associates provided medical editing expertise.Original Article
format article
author Chynn EW
Givergis R
Wong SH
Wang XJ
author_facet Chynn EW
Givergis R
Wong SH
Wang XJ
author_sort Chynn EW
title Corrigendum
title_short Corrigendum
title_full Corrigendum
title_fullStr Corrigendum
title_full_unstemmed Corrigendum
title_sort corrigendum
publisher Dove Medical Press
publishDate 2011
url https://doaj.org/article/9e8cc5f836c543cd99d613e62ca1fa01
work_keys_str_mv AT chynnew corrigendum
AT givergisr corrigendum
AT wongsh corrigendum
AT wangxj corrigendum
_version_ 1718402365784064000